MyAverix Finance
US · Healthcare
Liminatus Pharma, Inc. Class A Common Stock (LIMN)
Biotechnology
Liminatus Pharma, Inc. Class A Common Stock (LIMN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-19, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LIMN
Liminatus Pharma, Inc. Class A Common Stock (LIMN) — FAQ
What is LIMN's P/E ratio?
The price-to-earnings (P/E) ratio for Liminatus Pharma, Inc. Class A Common Stock (LIMN) is 25.00 (data as of 2026-05-19).
Does Liminatus Pharma, Inc. Class A Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Liminatus Pharma, Inc. Class A Common Stock (LIMN). Check the MyAverix Finance app for the latest dividend data.
What sector is Liminatus Pharma, Inc. Class A Common Stock in?
Liminatus Pharma, Inc. Class A Common Stock (LIMN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is LIMN listed on?
LIMN is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.